GSE210655
Protection of TLR5 agonist, CBLB502, against cisplatin treated mouse liver and kidney
TLR5 agonist CBLB502 has been reported playing protective effects again IR, Here we find CBLB502 might protect cis-platin induced liver and kidney damages. Overall design: C57BL/6 mice were treated 20mg/kg cis-platin i.p., CBLB502 were pre-treated with 0.2mg/kg at 30min before aminstation of cis-platin, 72 h later, liver and kidney were collected and performed RNA sequencing analysys.